The import of blood-grouping reagents to Japan is expected to gradually increase from $19.022 million in 2024 to $20.174 million in 2028. This indicates a steady upward trend, with a year-on-year increase of about 1.56% on average. The compound annual growth rate (CAGR) over these five years is approximately 1.49%. In 2023, the import value stood at a slightly lower level, emphasizing the continuous growth trajectory projected into 2024 and beyond.
Future trends to watch for include:
- Advancements in healthcare and diagnostic technologies, which may drive demand for more sophisticated blood-grouping reagents.
- Changes in Japan's healthcare policies and infrastructure investments, potentially affecting import volumes.
- Global supply chain dynamics and geopolitical factors, which could influence import conditions and costs.
